A mechanism by which insulin-like growth factors promote brain plasticity has been found by research at the Max Planck Florida Institute for Neuroscience.
The insulin superfamily of hormones, which includes insulin, insulin-like growth factor 1 (IGF1), and insulin-like growth factor 2 (IGF2), are essential for healthy brain development and function, including learning and memory, in addition to regulating blood sugar, metabolism, and growth.
These hormones can either be produced directly in neurons and glial cells in the brain or can reach the bloodstream from the liver. The IGF1 receptor is one of the receptors they bind to, activating signals that control the development and activity of neurons. This signaling pathway’s disruption contributes to disorders including Alzheimer’s and cognitive decline.
Scientists studied the activation of this signaling pathway in the hippocampus, a part of the brain important for learning and memory, to comprehend how IGF1 and IGF2 enhance brain health. They were particularly interested in determining whether IGF signaling was active during synaptic plasticity, the biological mechanism that fortifies neural connections during memory creation and guards against cognitive loss. Science Advances is the journal where the study is published.
Scientists at Max Planck were able to see the activity of the signaling pathway involved in plasticity as a result of the development of a biosensor that could recognize whether the IGF1-Receptor was activated. The investigators noticed that the IGF1-Receptor was strongly active in the strengthening synapse and neighboring synapses while a synapse was going through plasticity. During synaptic plasticity, this receptor activation was essential for synapse strengthening and development. However, it was unclear from where the IGF that triggers the receptor was originating.
Lead researcher and first author of the scientific publication, Dr. Xun Tu, however, described how being able to visualize the receptor activation during plasticity gave them a clue. “The fact that the activation of the IGF-receptor was localized near the synapse undergoing plasticity suggested that IGF1 or IGF2 might be produced in hippocampal neurons and locally released during plasticity,” she explained.
The researchers investigated this theory by determining if hippocampus neurons could create and release IGF1 and IGF2.
It’s interesting that they discovered a differential in IGF1 and IGF2 synthesis specific to certain regions. IGF1 was produced by the CA1 neurons in the hippocampus, while IGF2 was produced by the CA3 neurons. IGF was released when either CA1 or CA3 neurons were stimulated in a manner that mirrored synaptic plasticity. Importantly, the activation of the IGF1-Receptor during plasticity and synaptic development and strengthening was prevented when the scientists interfered with the neurons’ ability to generate IGF.
Senior author on the publication and Max Planck Scientific Director, Dr. Ryohei Yasuda, summarized the findings. “This work reveals a local, autocrine mechanism in neurons that is critical for brain plasticity. When a synapse undergoes plasticity, IGF is released locally to activate the IGF1-Receptor on the same neuron. Disrupting this mechanism impairs the plasticity, highlighting its critical role in maintaining cognitive health.”
This new mechanism’s discovery clarifies how memories are stored in the brain and emphasizes the value of further research on the insulin superfamily of brain hormones. The researchers are hoping that by figuring out the method through which IGF hormones promote brain plasticity, they will be able to investigate whether blocking this signaling pathway could delay cognitive aging and treat conditions like Alzheimer’s.
more recommended stories
-
Air Pollution Hurts Brain Health in Just 4 Hours
Air Pollution Blurs the Mind, Impairs.
-
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders
Urgent treatment solutions are needed for.
-
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences Division
The High-Level Meeting on antimicrobial resistance.
-
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences Division
The installation was commissioned to mark.
-
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences Division
Scientists at the University of Oxford,.
-
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences Division
Antimicrobial resistance (AMR) threatens the foundation.
-
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences Division
The TyVOID study, published in the Lancet, measured the.
-
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences Division
The research addresses the long-recognized poor.
-
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences Division
Only 30 prizes are awarded throughout.
-
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences Division
The Nikon Small World competition, often.
Leave a Comment